- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Enzo Biochem | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
ENZO BIOCHEM INC.
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
|
|
| Symbol: |
ENZ |
| Exchange(s): |
New York Stock Exchange |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Jul 31, 2009
12 Months
us$
|
Jul 31, 2008
12 Months
us$
|
Jul 31, 2007
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
89,570
|
77,790
|
52,900
|
31.03
|
|
Earnings before Interest & Tax ($000)
|
-23,470
|
-10,890
|
-13,170
|
N/A
|
|
Profit/Loss ($000)
|
-23,560
|
-10,650
|
-13,260
|
N/A
|
|
Earnings per Share
|
-0.63
|
-0.29
|
-0.38
|
N/A
|
|
Total Assets ($000)
|
133,120
|
154,520
|
159,000
|
9.45
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity
|
-18.47
|
-7.60
|
-11.17
|
|
|
Employees
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Jan 31, 2010,us$
|
12 Months ended
Jan 31, 2009,us$
|
%Change
|
|
Total Revenue ($000)
|
N/A
|
82,110
|
N/A
|
|
Profit/Loss ($000)
|
N/A
|
-19,410
|
N/A
|
|
Earnings per Share
|
N/A
|
-0.52
|
N/A
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
37,980,000
|
37,390,000
|
|
|
|
|
|
COMPANY INFORMATION
|
| Key Personnel |
| CEO: Elazar Rabbani Ph.D., Chmn.; C.E.O. |
| CFO: Barry W. Weiner, Presi.; C.F.O.; Dir. |
| |
| Contact Information |
| Address: |
527 Madison Avenue,
New York,
NY,
10022 |
Phone: |
212-583-0100 |
| Fax: |
212-583-0150 |
| Web Address: |
www.enzo.com |
| E-Mail : |
info@corp.enzobio.com |
| |
| Incorporation:
| United States |
| |
|
Securities:
|
ENZ-N
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
